Delivery Order SPE2DB24D8003-SPE2DB25FJUCC
Award Date
3/27/25
Potential Completion Date
3/28/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,051.20, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a firm fixed price of $2,798.42 and a performance period through March 6, 2025. Dakota Drug, Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical...
This is a delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) under the DLA Troop Support Medical's ECAT Generation V Program. The contract is for the delivery of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a ceiling value of $1,539.84 and a period of performance through February 11, 2025. Dakota Drug, Inc. also holds a larger single-award Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,312.08, is for the delivery of 4,567,331,268 units of the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of February 21, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a firm fixed-price, with a ceiling value of $2,810.29 and a period of performance through January 8, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,608.64 contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period ending on June 6, 2024. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the ECAT Generation V Program, which allows...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation. The contract, valued at $1,747.34, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of December 31, 2024. Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, holding a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract has a ceiling value of $2,709.91 and is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 7, 2025. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, holding a significant single-award...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,392.45, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period ending on January 8, 2025. Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, providing a range of pharmaceutical and medical products to support U.S. Armed Forces...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $1,312.08 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) worth $999,999,999.00 with the DLA Troop Support Medical under the ECAT Generation V Program, which allows the company to provide a wide range of pharmaceutical products,...